SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-353388
Filing Date
2018-12-19
Accepted
2018-12-19 17:06:34
Documents
1
Effectiveness Date
2018-12-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A d675330ddefa14a.htm DEFA14A 29095
  Complete submission text file 0001193125-18-353388.txt   30306
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35405 | Film No.: 181244002
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences